|
⚲
|
| Keyboard |
| Acrivon Therapeutics Inc | |
|---|---|
| Ticker | ACRV |
| CIK # | 0001781174 |
| CUSIP | 004890109 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 480 Arsenal Way, Suite 100, Watertown, MA 02472 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Acrivon Therapeutics Inc | 2021-11-23 | 100.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001781174] | 10-K | |
| [0001781174] | 10-Q | |
| [0001781174] | 3 | |
| [0001781174] | 4 | |
| [0001781174] | 8-K | |
| [0001781174] | D | |
| [0001781174] | SC 13D | |
| [0001781174] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Citadel Advisors LLC | Acrivon Therapeutics Inc | [2025-11-21] | 0.0 |
| Marshall Wace North America LP | Acrivon Therapeutics Inc | [2023-02-14] | 5.9 |
| Chione Ltd | Acrivon Therapeutics Inc | [2022-11-28] | 18.5 |
| RA Capital Management LP | Acrivon Therapeutics Inc | [2022-11-28] | 23.07 |
| Sands Capital Life Sciences Pulse Fund II LP | Acrivon Therapeutics Inc | [2022-11-25] | 7.9 |
| Citadel Advisors LLC | Acrivon Therapeutics Inc | [2022-11-21] | 7.8 |
| Perceptive Advisors LLC | Acrivon Therapeutics Inc | [2022-11-18] | 14.4 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Peterson Katharine
Stock Option (Right to Buy) · derivative
|
2026-03-01 | Grant | 31,900 | $0.00 | |
|
Blume-Jensen Peter +1
Stock Option (Right to Buy) · derivative
|
2026-03-01 | Grant | 417,210 | $0.00 | |
|
Blume-Jensen Peter +1
Stock Option (Right to Buy) · derivative
|
2026-03-01 | Grant | 185,495 | $0.00 | |
|
Devroe Eric
Stock Option (Right to Buy) · derivative
|
2026-03-01 | Grant | 186,728 | $0.00 | |
|
Gamelin Erick
Stock Option (Right to Buy) · derivative
|
2026-03-01 | Grant | 94,946 | $0.00 | |
|
Levy Adam D
Stock Option (Right to Buy) · derivative
|
2026-03-01 | Grant | 132,925 | $0.00 | |
|
Miller Mary
Stock Option (Right to Buy) · derivative
|
2026-03-01 | Grant | 129,760 | $0.00 | |
|
Mirza Mansoor Raza
Stock Option (Right to Buy) · derivative
|
2026-03-01 | Grant | 174,068 | $0.00 | |
|
Blume-Jensen Peter +1
Common Stock
|
2026-02-21 | Tax withheld | 14,265 | $1.53 | 21,825 |
|
Devroe Eric
Common Stock
|
2026-02-14 | Tax withheld | 723 | $1.63 | 1,178 |
|
Miller Mary
Common Stock
|
2026-02-14 | Tax withheld | 217 | $1.63 | 354 |
|
Peterson Katharine
Common Stock
|
2026-02-14 | Tax withheld | 116 | $1.63 | 189 |
|
Gamelin Erick
Common Stock
|
2026-02-14 | Tax withheld | 471 | $1.63 | 768 |
|
Blume-Jensen Peter +1
Common Stock
|
2026-02-14 | Tax withheld | 1,302 | $1.63 | 2,122 |
|
Blume-Jensen Peter +1
Common Stock
|
2026-02-14 | Tax withheld | 579 | $1.63 | 944 |
|
Miller Mary
Common Stock
|
2026-01-17 | Tax withheld | 659 | $1.98 | 1,305 |
|
Levy Adam D
Common Stock
|
2026-01-14 | Buy | 8,832 | $1.70 | 15,014 |
|
Blume-Jensen Peter +1
Common Stock
|
2026-01-14 | Buy | 49,000 | $1.68 | 82,320 |
|
Devroe Eric
Common Stock
|
2026-01-13 | Buy | 10,000 | $1.72 | 17,200 |
|
Blume-Jensen Peter +1
Common Stock
|
2025-11-21 | Tax withheld | 19,904 | $2.30 | 45,779 |
| showing 20 of 185 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 44 | 16,236,130 |
| 2025-12-31 | 48 | 18,610,761 |
| 2025-09-30 | 48 | 17,524,955 |
| 2025-06-30 | 53 | 17,650,647 |
| 2025-03-31 | 64 | 22,531,267 |
| 2024-12-31 | 64 | 23,263,627 |
| 2024-09-30 | 56 | 23,124,784 |
| 2024-06-30 | 56 | 23,470,379 |
| 2024-03-31 | 49 | 15,284,939 |
| 2023-12-31 | 43 | 15,368,037 |
| 2023-09-30 | 44 | 15,093,902 |
| 2023-06-30 | 41 | 15,126,531 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| AAF Wealth Management LLC | [2026-06-30] | SOLE | 0 | 10,678 |
| Crews Bank & Trust | [2026-06-30] | SOLE | 1,044 | 1,044 | Prev | Page 1 | Next |